Thomas Ziebart - Concepedia

Author

Thomas Ziebart

Johannes Gutenberg University Mainz ORCID

Also Known As

T Ziebart, T. Ziebart, THOMAS ZIEBART, Thomas Ziebart

Publications

Citations

H-Index

Concepts

All Affiliations

Johannes Gutenberg University Mainz University Medical Center of the Johannes Gutenberg University Mainz Philipps University of Marburg Universitätsklinikum Gießen und Marburg Bundeswehrzentralkrankenhaus Koblenz

About

Thomas Ziebart is an author at Johannes Gutenberg University Mainz specializing in medicine, cell biology, and osteoporosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	36	1.8K
2	Engineering	8	8	412
3	Health Sciences	6	6	378
4	Anesthesia	1	1	13
5	Applied Physiology	1	1	71

Thomas Ziebart

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
<i>Ex vivo</i> pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy Ken-ichiro Sasaki, Christopher Heeschen, Alexandra Aicher, Proceedings of the National Academy of Sciences	2006	210
Engineering a morphogenetically active hydrogel for bioprinting of bioartificial tissue derived from human osteoblast-like SaOS-2 cells Meik Neufurth, Xiaohong Wang, Heinz C. Schröder, Biomaterials Regenerative MedicineTissue EngineeringHydrogelsSynthetic Bone SubstituteBioartificial Tissue	2014	185
Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells Christian Walter, Marc Klein, Andreas Pabst, Clinical Oral Investigations MechanobiologyEndothelial CellsBone Morphogenic ProteinMedicinePhysiology	2009	148
Submicron Scale‐Structured Hydrophilic Titanium Surfaces Promote Early Osteogenic Gene Response for Cell Adhesion and Cell Differentiation M Klein, Ana Popović‐Bijelić, Thomas Ziebart, Clinical Implant Dentistry and Related Research	2011	133
Bisphosphonates: restrictions for vasculogenesis and angiogenesis: inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro Thomas Ziebart, Andreas Pabst, M Klein, Clinical Oral Investigations Endothelial Cell PathobiologyEndothelial Progenitor CellsAngiogenesisEndothelial CellsBone Morphogenic Protein	2009	121
Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts <i>in vitro</i> Christian Walter, Andreas Pabst, Thomas Ziebart, Oral Diseases	2010	114
The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes—in vitro study Andreas Pabst, Thomas Ziebart, Felix P. Koch, Clinical Oral Investigations MedicineOral BiologyCell DeathDermatologyPharmacology	2011	106
Sustained Persistence of Transplanted Proangiogenic Cells Contributes to Neovascularization and Cardiac Function After Ischemia Thomas Ziebart, Chang‐Hwan Yoon, Thomas Trepels, Circulation Research Cardiac FunctionImmunologyCardiac RegenerationVascular LeakageCellular Physiology	2008	99
Geranylgeraniol – A new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw Thomas Ziebart, Felix Koch, M Klein, Oral Oncology Bone DiseaseMedicineBone MetabolismBone HomeostasisMaxillofacial Surgery	2011	80
Immediate effects of acupuncture on strength performance: a randomized, controlled crossover trial Markus Hübscher, Lutz Vogt, Thomas Ziebart, European Journal of Applied Physiology KinesiologyHealth SciencesCrossover TrialPhysical FitnessExercise	2010	71

Page 1